WO2011024039A1 - Synthesis of novel 5-(2-(phenylsulfonyl)ethyl)-1h-indole derivatives - Google Patents
Synthesis of novel 5-(2-(phenylsulfonyl)ethyl)-1h-indole derivatives Download PDFInfo
- Publication number
- WO2011024039A1 WO2011024039A1 PCT/IB2010/001886 IB2010001886W WO2011024039A1 WO 2011024039 A1 WO2011024039 A1 WO 2011024039A1 IB 2010001886 W IB2010001886 W IB 2010001886W WO 2011024039 A1 WO2011024039 A1 WO 2011024039A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- product
- scheme
- ethyl
- potassium carbonate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
Definitions
- An obji»ctive ⁇ Ftl ie present Invention is to develop commercially viable methods for the synthesis of 5- [(2-ph ⁇ yisulf m) )ethyl]-lH-lndole of formula II,
- R 1 and R 2 arc the same Q ⁇ different and each independently
- Another!I biij j,efetife of the present invention is to convert the product formula Il to formula I in high yields.
- R 1 and R 2 arc the same or different and each independently represent a hydrogen, fluorine, or diflower alkyl)amtflo, acyi, or alkoxy caibonyl or chlorine atom, or a lower atkyl, lower alkoxy, nitro.
- rya ⁇ , ⁇ minol ⁇ wer alkylamine group
- R 5 is Acetyl, propyl, trlfluoacetyt,
- inorganic base is selected from the group consisting sod liiuu ⁇ il cirbo , potassium carbonate or cesium carbonate and the organic base is selected from the gro uupp to ⁇ s iiisstti ig of triethylamine, diisopropytethylamine, N-meth ⁇ lmorpholine, pyridine, ⁇ -picoline, ⁇ - picolinb ⁇ i v-p co I ⁇ e.
- a phas Ie t irans er catalyst is used, when an inorganic base is used.
- the PTC is selected from the group consis nit ⁇ ft! of z ⁇ hriethylammo ⁇ ium chloride, tetrabut ⁇ lar ⁇ r ⁇ o ⁇ ium bromide, tetrob ⁇ tylammonium hydrogeri lsulp ia1 e, 15 Crown 5 or 10 Crown 6.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Abstract
An objective of the present invention is to develop commercially viable methods for the synthesis of 5-[2-phenylsulfony)ethyl]-1H-indole of Formule (II), where R1 and R2 are same or different and each independently represent a hydrogen, fluorine, or di(lower alkyl)amino, acyl, or alkoxy carbonyl or chlorine atom, or a lower alkyl, lower alkoxy, nitro, cyano, aminolower alkylamine group Formula (II). Another objective of the present invention is to convert the product Formula (II) to Formula (I) in high yields, where R1 and R2 are same or different and each independently represent a hydrogen, fluorine, or di(lower alkyl)amino, acyl, or alkoxy carbonyl or chlorine atom, or a lower alkyl, lower alkoxy, nitro, cyano, aminolower alkylamine group Formula (I). One of the first processes attempted was by reacting the indole derivative of Formula (III) with aryl vinyl sulphones of Formula (V) as shown in Scheme-III. Another process attempted was by reacting the aniline derivative of Formula (VI) with aryl sulphones of Formula (VII) as shown in Scheme-III. Scheme IV.
Description
Title: 1 ! SψrtΗESlS OF NOVEL 5-(2-(PHENYLSULFONYL) ETHYL)-1H-INDOLE
DERϊVjpT bi
BACKriROUN Q = THE iNVENTlON:
The syfitfi .sis >f -[(2-phenyJsulfony)ethenyl]-lH-indole of formula II, is described in US6201131.
There areitwe examples describing the synthesis of the compound of formula Il
Exam es Tibes the process by the reaction of 5-bτomoiπdole (III) with the methyl sulfonyl derivative of f»enyfsuffonyj)ethanσl (IV). The process is given in scheme-! o /
^. -0V J)
Br' *^
IV m
Scheme-I
In this pH>ce< ;, 1 ie product is obtained in 23% yield.
r
Exempli jl3 f as described the synthesis by the reaction of 5-iodoindole (Ilia) with trifluoacetyl derivative of (2-bh.lW«s ilfi ιnyl)ethanol (IV) as represented in scheme Il
,CF3 «s ^^ J
\
o Il
IY ma IV
5cheme-ll
Usfngt^ls pr >cι ss, the product is obtained in about 5296 yield.
By bόttjlthe ne hods, yields of the required product are moderate to good.
5-[(2-pfti.nyl ul onyJethenyll-lH-iπdole (If) is an important building block in developing indole derivatives < f tt ierapcutic importance.
Hence there is in urgent requirement to achieve excellent yields of these types of indole derivatives
SUMNJAάV O! Jl E INVENTION:
An obji»ctive < Ftl ie present Invention is to develop commercially viable methods for the synthesis of 5- [(2-phέπyisulf m) )ethyl]-lH-lndole of formula II,
where R1 and R2 arc the same QΓ different and each independently
represent a hydrogen, fluorine, or diflowcr αikyOamino, scyl, or
alkony caibβnyl or chlorine βom, or a lonπr nlkyl, lower aJkςBCV.
niito, cyaπσ, amiπolower alkylemmc group
Formula Il
Another!I biij j,efetife of the present invention is to convert the product formula Il to formula I in high yields.
where Tl1 and R2 ore tho same βr different and rarh independently
represent a hydrogen, fluorine, or di(lower altyl)ajnhio, aeyl, or
aϋcoxy carbonyl αr chlorine atom, or a loner alkyl, lower βJkoxy,
nitro. ι-ynnn, aminotσwer aHcylaminc group
Formula I
One of the ffrstl processes attempted was by reacting the indole derivative of formula III with aryl vinyl
I ' J l
sulphυries oqfojmula V as shown in Scheme-Ill .
Scheme-Ill
Another! brnφsfj attempted was by reacting the aniline derivative of formula Vl with aryl sulphones of formulaml aa sHown in Scheme-Ill.
Scheme-IV
Scheme-Ill a
where R1 and R2 arc the same or different and each independently represent a hydrogen, fluorine, or diflower alkyl)amtflo, acyi, or alkoxy caibonyl or chlorine atom, or a lower atkyl, lower alkoxy, nitro. ryaππ, αminolσwer alkylamine group
Foπrnda-V
R5 is Acetyl, propyl, trlfluoacetyt,
fcbuftw rartooπyl, benzyloxy carbonyl or fluoroa/y, oxycartaonyl
Vl
VII
Scheme-V
An orgbnit o in vganic base is used, wherein inorganic base is selected from the group consisting sod liiuuππil cirbo , potassium carbonate or cesium carbonate and the organic base is selected from the gro uupp toπs iiisstti ig of triethylamine, diisopropytethylamine, N-methγlmorpholine, pyridine, α-picoline, β- picolinb όi v-p co Iπe.
A phas Ie t irans er catalyst is used, when an inorganic base is used. The PTC is selected from the group consis nitπft! of zγhriethylammoπium chloride, tetrabutγlarπrπoπium bromide, tetrobυtylammonium hydrogeri lsulp ia1 e, 15 Crown 5 or 10 Crown 6.
The reaciron I eferably carried out at a temperature of 30 to 1500C, more preferably at 40-1300C and most preterab y 160-1200C.
On compitetlo per TLC monitoring, the reaction mixture is worked up to give the product of formula x I!
The product c Ffc rmula X Is converted to the product of formula Xl as per scheme VII
Fonniilfr-Xl
Scheme-VII
Scheme-VIH
EXAMPlifeS in the follow ng examples, the preferred embodiments of the present invention are described only by way of (llυst Ig the process of the invention. However, these do not limit the scope of the present fπvetiUc/n fn < rvy way.
Examplefl
Examples-Ill
N-(4-(2-tøher rts{jlfoπyl)ethyl)pheπy!)acetamide, VIII
20gm ofA-(2 _hl sroethylsυlfonyl) benzene in 125ml of dichloromethαne was cooled to S0C. 13gm of N- phenylacetan id ! was added to the reaction mixture and 55gm of anhydrous AlG3 was slowly added maintaining i he temperature of the reaction mixture at S0C- After completion of the reaction, the reaction1 imix ur > was quenched into 500ml of ice water containing hydrochloric acid. Separated dichlorσmetr an s was concentrated to give 7figm of N-(4-(2-(phenylsulfonγl)ethyl)phenyl)acetamide as waxy solid.
Examμl^lV
N-(2,2-dfeth( xy !thyl)-N-(4-(2-(phenylsυlfonyl)ethyl)phenyl)acetamide, X
10gm of|N-(' -(phenylsulfonyl)ethyl)phe«yl)acetamide was dissolved in 100ml of dimethyfformamide, 0.5gm of t« tπ butylammoniumbromide and 4gm of potassium carbonate added. 7.5gm of 2- bromoάletd Ji iyde diethyl βcctαl was added and temperature was raised to 65ήC After the reaction was cortiplet 3d the reaction mixture was filtered and filtrate added into 300ml of water. Product was extract*-! ir < lchtorompthane and concentrated to get llgm of N-(2,2-diethoxyethyl)-N-(4-(2- (pheny&ulfo tyl ethyf)pheπyl)acetamide.
obtained, N-aι^βt^l-S-{2-(ph*>nylsιilfoπvl)ethvl)-lH-iπdole 6.0gm, showed a melting point
Example^VI
5-(2-(Phenyis lf<jnyl)ethyl)-lH-tndo!e, I
5gm of sN-ac sty -5-(2-(phenylsulfonγl)ethyl)-lH-ϊndole was dissolved in 40ml αf ethanol and 1.5gm of potassium ca be nate added. The reaction was stirred at room temperature till the reaction complete, The reaction mi cture filtered and Nitrate concentrated under reduced pressure to give 4gm of 5-(7- (phenγlsiilfor !thyl)-lH-indole
Claims
to
ύ) rβict'Aig product of formufa-VlH with product of formuta-!X to get product of formυla-X
same or amino,
6. ^s cl m id in claim Ib, wherein, catalytic hydrogeπation is carried out preferably in the pfresi of 10% pH/r..
7- As c !d in claim 2a, wherein, Fried el -Crafts reaction is carried In solvent selected from HhethΛ e chloride or dichloromethane, preferably dϊchloromethane
8. As cl m ;d in claim 2b, wherein, the reaction of product of formula VI(I with the product of form IX is carried out selected from aeetonitrile, N,N-dimethytformamϊrifi, N,N-dimethyl dceta e or N-methyl pyrrolidin-2-one in the presence of a base selected from sodium carbo e, potassium carbonate, cesium carbonate, triethyl amine, diisσpropyl ethylamine or N- meth rr orpholine, preferably in N,N-dimethγl formamide and potassium carbonate
9. As cl m id in claim 2c, wherein, the cyclizatlσn of the product of formula X to the product of form Xl Is carried out a reagent chosen from sulphuric acid, trifluoro acetatic acid or πγdi rch jric acid at 40βC to 100βC, preferably in sulphuric acid at 60-7(TC
10. As cl; m d in claim 2d, wherein, the conversion of the product of formula-X to formula-l is
έarrli ut a selected from methanol, ethanol, lsoproanol or n-butaπol in the presence of a base cted from sodium carbonate, potassium carbonate or cesium carbonate aτ 60-120"c, prefe y in ethanol containing potassium carbonate at 6O-80°C
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2030/CHE/2009 | 2009-08-25 | ||
| IN2030CH2009 | 2009-08-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2011024039A1 true WO2011024039A1 (en) | 2011-03-03 |
Family
ID=43627318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IB2010/001886 Ceased WO2011024039A1 (en) | 2009-08-25 | 2010-07-30 | Synthesis of novel 5-(2-(phenylsulfonyl)ethyl)-1h-indole derivatives |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2011024039A1 (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992006973A1 (en) * | 1990-10-15 | 1992-04-30 | Pfizer Inc. | Indole derivatives |
| US5545644A (en) * | 1990-10-15 | 1996-08-13 | Pfizer Inc. | Indole derivatives |
| EP1088817A2 (en) * | 1999-10-01 | 2001-04-04 | Pfizer Limited | Process for the preparation of 3-acyl-indoles |
| WO2002050063A1 (en) * | 2000-12-20 | 2002-06-27 | Pfizer Limited | New process |
-
2010
- 2010-07-30 WO PCT/IB2010/001886 patent/WO2011024039A1/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992006973A1 (en) * | 1990-10-15 | 1992-04-30 | Pfizer Inc. | Indole derivatives |
| US5545644A (en) * | 1990-10-15 | 1996-08-13 | Pfizer Inc. | Indole derivatives |
| EP1088817A2 (en) * | 1999-10-01 | 2001-04-04 | Pfizer Limited | Process for the preparation of 3-acyl-indoles |
| WO2002050063A1 (en) * | 2000-12-20 | 2002-06-27 | Pfizer Limited | New process |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106061972B (en) | 5-Fluoro-4-imino-3-(alkyl/substituted alkyl)-1-(arylsulfonyl)-3,4-dihydropyrimidin-2(1H)-one and preparation method thereof | |
| JP7728952B2 (en) | Pharmaceutical processes and intermediates | |
| CN108424395B (en) | Preparation method of sulfentrazone | |
| JP5689321B2 (en) | Process for producing 2-amino-4-trifluoromethylpyridines | |
| WO2011024039A1 (en) | Synthesis of novel 5-(2-(phenylsulfonyl)ethyl)-1h-indole derivatives | |
| JP6197868B2 (en) | Method for producing pyridazinone compound | |
| CA3048084A1 (en) | Protected oxadiazacyclic compounds, method for preparing oxadiazacyclic compounds and uses thereof | |
| CN103387547B (en) | A kind of method preparing phonetic mite amine | |
| TW201002670A (en) | Process for preparing substituted biphenylanilides | |
| WO2011016228A1 (en) | Method for producing 4,6-dialkoxy-2-cyanomethylpyrimidine and synthetic intermediate thereof | |
| JP2009035508A (en) | Process for producing optically active carboxylic acid | |
| KR101686087B1 (en) | Process for Production of Optically Active Indoline Derivatives or Salts Thereof | |
| AU2006240772B2 (en) | Method for producing nicotinic acid derivative or salt thereof | |
| JP4418430B2 (en) | Method for producing sulfonamide-containing indole compound | |
| JP2011057575A (en) | Manufacturing method of 4-hydroxybenzothiophene derivative | |
| JP2009126785A (en) | Method for producing 2-iodo-3,4-dimethoxybenzonitrile | |
| JP2009126784A (en) | A method for producing 2-iodo-3,4-dimethoxybenzonitrile. | |
| US7122674B2 (en) | Process for preparing high-purity hydroxyindolylglyoxylamides | |
| JP2004010601A (en) | Process for producing indole derivative and useful intermediate therefor | |
| KR100566562B1 (en) | Manufacturing method of sumatriptan | |
| JP2011526257A (en) | Process for producing N-phenyl-N- (4-piperidinyl) amide salt | |
| KR102157528B1 (en) | Method for producing 2-aminonicotinic acid benzyl ester derivative | |
| JPH07316137A (en) | Method for producing (hexahydro-1-methyl-1H-azepin-4-yl) -hydrazine or a salt thereof | |
| JPWO2005063678A1 (en) | Method for producing phenylacetic acid derivative | |
| KR101152607B1 (en) | Process for preparing 6-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-3-pyridin-4-yl-pyrazolo[1,5-a]pyrimidine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10811331 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 10811331 Country of ref document: EP Kind code of ref document: A1 |